Screening of Thalassaemia carrier By Nanotechnology based methods.
Label Free Characterization for Hematopoietic Stem Cells by Nanotechnology based methods.
Development of Spion( super paramagnetic iron oxide nanoparticle) based ferritin sensor.
Co-investigator in the project- ‘Gene micromapping of Thalassaemia in West Bengal’.
Co-investigator in the project- ‘Study on Aplastic Anemia, Etiological role of environmental and genetic factors in Eastern India funded by WB state DST
Clinical Trials- Co investigator of the following clinical trials:
a phase 3, randomized, double-blind study of pf-05280586versus rituximab for the first-line treatment of patientswith cd20-positive,
low tumor burden, follicular lymphoma.
a randomized, double-blind, phase iii study comparing biosimilar rituximab (rtxm83) plus chop chemotherapy versus a reference
rituximab plus chop (r-chop) in patients with diffuse large b-cell lymphoma (dlbcl)given as first line
a prospective, open-label, multi-centric study to evaluate the efficacy and safety of inj. romiplostim of intas pharmaceuticals ltd.
in adult indian patients with chronic refractory idiopathic thrombocytopenic purpura.
an open label single arm multicentric study evaluating the safety and efficacy of intranasal methylcobalamin in the
treatment and maintainance therapy of vitamin b12 deficiency